BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28799303)

  • 1. Clinical Profile of Dysphagia in Patients with Parkinson's Disease, Progressive Supranuclear Palsy and Multiple System Atrophy.
    Sulena ; Gupta D; Sharma AK; Singh B
    J Assoc Physicians India; 2017 Aug; 65(8):32-37. PubMed ID: 28799303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An assessment of dysphagia using videofluorography in Parkinson's disease and progressive supranuclear palsy].
    Ichihara N; Ichihara SI; Fujii S; Touge T; Nishioka M
    Rinsho Shinkeigaku; 2000 Nov; 40(11):1076-82. PubMed ID: 11332186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
    Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic patterns of oral-pharyngeal swallowing in parkinsonian syndromes.
    Alfonsi E; Versino M; Merlo IM; Pacchetti C; Martignoni E; Bertino G; Moglia A; Tassorelli C; Nappi G
    Neurology; 2007 Feb; 68(8):583-9. PubMed ID: 17310027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysphagia in Progressive Supranuclear Palsy.
    Clark HM; Stierwalt JAG; Tosakulwong N; Botha H; Ali F; Whitwell JL; Josephs KA
    Dysphagia; 2020 Aug; 35(4):667-676. PubMed ID: 31676923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
    Krishnan S; Mathuranath PS; Sarma S; Kishore A
    Neurol India; 2006 Sep; 54(3):268-72. PubMed ID: 16936386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.
    De Pablo-Fernández E; Courtney R; Warner TT; Holton JL
    JAMA Neurol; 2018 Aug; 75(8):1008-1012. PubMed ID: 29710120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum uric acid levels in Parkinson's disease and related disorders.
    Sakuta H; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Watanabe Y; Hirata K
    Brain Behav; 2017 Jan; 7(1):e00598. PubMed ID: 28127516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease.
    Kass-Iliyya L; Kobylecki C; McDonald KR; Gerhard A; Silverdale MA
    Brain Behav; 2015 May; 5(5):e00320. PubMed ID: 25874161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
    Kim KJ; Jeong SJ; Kim JM
    Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
    Sachin S; Shukla G; Goyal V; Singh S; Aggarwal V; ; Behari M
    Neurol India; 2008; 56(2):122-6. PubMed ID: 18688134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Ashour R; Jankovic J
    Mov Disord; 2006 Nov; 21(11):1856-63. PubMed ID: 16941460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy.
    Warnecke T; Oelenberg S; Teismann I; Hamacher C; Lohmann H; Ringelstein EB; Dziewas R
    Mov Disord; 2010 Jul; 25(9):1239-45. PubMed ID: 20629130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Early Oropharyngeal Dysphagia in Patients with Multiple System Atrophy.
    Lee HH; Seo HG; Kim KD; Lee SH; Lee WH; Oh BM; Lee WW; Kim Y; Kim A; Kim HJ; Jeon B; Han TR
    Neurodegener Dis; 2018; 18(2-3):84-90. PubMed ID: 29621788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
    Ozsancak C; Auzou P; Dujardin K; Quinn N; Destée A
    J Neurol; 2004 Nov; 251(11):1317-23. PubMed ID: 15592726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of nocturnal blood pressure fall in various extrapyramidal syndromes.
    Schmidt C; Berg D; ; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Reichmann H; Ziemssen T
    Mov Disord; 2009 Oct; 24(14):2136-42. PubMed ID: 19768815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct patterns of imprecise consonant articulation among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Tykalova T; Rusz J; Klempir J; Cmejla R; Ruzicka E
    Brain Lang; 2017 Feb; 165():1-9. PubMed ID: 27894006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
    Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F
    J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.